» Articles » PMID: 37095957

Folate-dependent Hypermobility Syndrome: A Proposed Mechanism and Diagnosis

Overview
Journal Heliyon
Specialty Social Sciences
Date 2023 Apr 25
PMID 37095957
Authors
Affiliations
Soon will be listed here.
Abstract

Hypermobility involves excessive flexibility and systemic manifestations of connective tissue fragility. We propose a folate-dependent hypermobility syndrome model based on clinical observations, and through a review of existing literature, we raise the possibility that hypermobility presentation may be dependent on folate status. In our model, decreased methylenetetrahydrofolate reductase (MTHFR) activity disrupts the regulation of the ECM-specific proteinase matrix metalloproteinase 2 (MMP-2), leading to high levels of MMP-2 and elevated MMP-2-mediated cleavage of the proteoglycan decorin. Cleavage of decorin leads ultimately to extracellular matrix (ECM) disorganization and increased fibrosis. This review aims to describe relationships between folate metabolism and key proteins in the ECM that can further explain the signs and symptoms associated with hypermobility, along with possible treatment with 5-methyltetrahydrofolate supplementation.

Citing Articles

Long COVID and hypermobility spectrum disorders have shared pathophysiology.

Ganesh R, Munipalli B Front Neurol. 2024; 15:1455498.

PMID: 39301475 PMC: 11410636. DOI: 10.3389/fneur.2024.1455498.


Joint Hypermobility Syndrome and Membrane Proteins: A Comprehensive Review.

Pliego-Arreaga R, Cervantes-Montelongo J, Silva-Martinez G, Tristan-Flores F, Pantoja-Hernandez M, Maldonado-Coronado J Biomolecules. 2024; 14(4).

PMID: 38672488 PMC: 11048254. DOI: 10.3390/biom14040472.


Prevalence of MTHFR Polymorphisms in Patients With Hypermobile Ehlers-Danlos Syndrome and Hypermobile Spectrum Disorders in a US Hypermobility Clinic.

Courseault J, Umar M, Bordnick P, Simons J, Volic M, Stock A ACR Open Rheumatol. 2024; 6(7):399-402.

PMID: 38523329 PMC: 11246825. DOI: 10.1002/acr2.11667.


Heterozygous THBS2 pathogenic variant causes Ehlers-Danlos syndrome with prominent vascular features in humans and mice.

Hadar N, Porgador O, Cohen I, Levi H, Dolgin V, Yogev Y Eur J Hum Genet. 2024; 32(5):550-557.

PMID: 38433265 PMC: 11061164. DOI: 10.1038/s41431-024-01559-1.

References
1.
Shane B . Folate status assessment history: implications for measurement of biomarkers in NHANES. Am J Clin Nutr. 2011; 94(1):337S-342S. PMC: 3127515. DOI: 10.3945/ajcn.111.013367. View

2.
Kamen B, Smith A . A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro. Adv Drug Deliv Rev. 2004; 56(8):1085-97. DOI: 10.1016/j.addr.2004.01.002. View

3.
Rossignol D, Frye R . Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis. J Pers Med. 2021; 11(11). PMC: 8622150. DOI: 10.3390/jpm11111141. View

4.
Turner D, Gorski P, Maasar M, Seaborne R, Baumert P, Brown A . DNA methylation across the genome in aged human skeletal muscle tissue and muscle-derived cells: the role of HOX genes and physical activity. Sci Rep. 2020; 10(1):15360. PMC: 7506549. DOI: 10.1038/s41598-020-72730-z. View

5.
Yanagishita M . Function of proteoglycans in the extracellular matrix. Acta Pathol Jpn. 1993; 43(6):283-93. DOI: 10.1111/j.1440-1827.1993.tb02569.x. View